Updated:
Immune
Immune is a family office based in Jefferson City, Missouri. Its principals, AUM, and investment strategy are not disclosed in any public source.
Immune
Immune is a family office headquartered in Jefferson City, Missouri. No founding year or named principals have been publicly disclosed. The firm does not maintain a public website or active LinkedIn presence, limiting available detail on its operational history or wealth origin. The office's investment strategy remains opaque. Without a public track record or disclosed holdings, it is not possible to confirm asset-class exposure, geographic footprint, or any portfolio companies. No data exists on direct investments, fund commitments, or co-investment partnerships. Team size and deployment capital are undisclosed. There is no record of recent operational events, philanthropic vehicles, or adjacent structures. The firm has not appeared in industry publications or regulatory filings in a manner that describes its activities beyond its name and location. What distinguishes Immune is its strong preference for privacy — it is not registered with any allocator database, does not issue press releases, and does not maintain a digital footprint. This posture suggests a conservative, single-family-office model deliberately avoiding external visibility.
General information
Firm type
Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Jefferson City
Corporate office
Jefferson City, MO, United States
Frequently asked questions
Who runs investment decisions at Immune?
No named principals or investment committee members for Immune are available in any public source. The firm does not publish a team page or disclose leadership outside of its registration documents.
Is Immune structured as a single family office or a multi-family office?
Public records do not specify whether Immune operates as a single-family office or a multi-family office. The absence of any disclosed external clients or pooled vehicles suggests a single-family office structure.
Does Immune participate in fund commitments or only direct deals?
There is no public information confirming whether Immune commits to external funds, makes direct investments, or both. All capital deployment methods remain undocumented.
What investment stages does Immune typically target?
No investment stage preferences have been attributed to Immune. There is no public record of venture, growth, or buyout exposure.
Which sectors does Immune explicitly avoid?
No sector restrictions have been stated by the firm. With no portfolio disclosures, it is not possible to identify any intentional exclusions.
Where does the underlying wealth come from?
The wealth origin for Immune is not disclosed. No connection to a specific family business, inheritance, or corporate sale has been reported.
Does Immune maintain philanthropic structures, and how are they separated?
There is no record of a philanthropic foundation or donor-advised fund linked to Immune. The firm does not appear in any charity database or grantmaking report.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: